News
We bring you up to date at all times: Discover the latest news from the chemical industry, analytics, lab technology and process engineering. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of the chemical industry: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 64,557 keywords from chemistry, pharmaceutics, material sciences and related science disciplines in the encyclopedia.
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.chemeurope.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
09-Jul-2004 - Avecia has won the 2004 'Innovation of the Year Award' from the Chemical Industries Association (CIA). The Award was given for the company's Pd EnCat(TM) palladium catalyst technology - a key to faster, cleaner chemistry in pharmaceutical production. The technology enables higher throughput ...
05-Feb-2004 - Avecia announced that it has completed the sale of its specialty Additives business, headquartered in Manchester, England, to The Lubrizol Corporation. This concludes an agreement previously announced on 22 December 2003. The Additives business had 2003 sales of approximately £30 million. ...
02-Oct-2003 - Avecia has been awarded a US $71.3 million contract to make 3 million doses of a new type of recombinant anthrax vaccine for the US Government's National Institute of Allergy and Infectious Diseases (NIAID). Scheduled for completion by late 2006, the contract will continue anthrax vaccine ...
07-Jul-2003 - Avecia announced today that it has signed a definitive agreement to sell substantially all of the assets and liabilities of its US-based Metal Extraction Products (MEP) and Intermediates & Stabilizers (I&S) businesses to Cytec Industries Inc for approximately US$97m in cash. Included in the sale ...
24-Jun-2003 - Avecia announced today that it has signed a definitive agreement to sell substantially all of the assets and liabilities of its US-based Metal Extraction Products (MEP) and Intermediates & Stabilizers (I&S) businesses to Cytec Industries Inc for approximately US$97m in cash. Included in the sale ...
13-Aug-2002 - Heubach announced the acquisition of Avecia’s pigments business, comprising high performance automotive pigments, phthalocyanine pigments, azo pigments and specialty pigment dispersions. The acquisition, which is effective from January 1st 2003 also provides Heubach with access to Avecia’s global ...
08-Nov-2001 - Avecia has added to the microbial gene expression technologies of its Biologics development and contract manufacturing operation with launch of the new 'pPOP’TM E.coli expression technology. Gene expression is a key part of the overall process for making recombinant protein pharmaceuticals. ...
11-Jun-2001 - Avecia today announced further expansion of the gene expression tool-kit of its Biotechnology contract manufacturing business with the licensing of the patented technology of XOMA Ltd. (Nasdaq:XOMA) for protein-based bio-pharmaceuticals production. Avecia will use XOMA’s bacterial cell ...
© 1997-2024 LUMITOS AG, All rights reserved